Acute Lung Injury: all 994 studies
Page 6 of 10. Open to participants first (156), then studies with results posted, then the rest; newest registration first within each.
- Tomographic Findings in COVID-19 and Influenza H1N1Status unknownNCT04499378
- Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19WithdrawnNCT04490486Phase 1
- Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDSWithdrawnNCT04482712Phase 1/2
- Safety and Effectiveness Assessment of the MakAir Artificial VentilatorTerminatedNCT04475185Not applicable
- Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 InfectionCompletedNCT04475068
- Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance TomographyCompletedNCT04473300
- Assessment of Preload Responsiveness in ARDS Patients During Prone PositionCompletedNCT04457739
- One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19CompletedNCT04457505
- Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19Active, not recruitingNCT04456361Early Phase 1
- Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)WithdrawnNCT04453371Phase 3
- Study of Decidual Stromal Cells to Treat COVID-19 Respiratory FailureCompletedNCT04451291Not applicable
- Knowledge, Attitude and Practice of Dental Students About COVID-19CompletedNCT04449081
- Comparison of Esophageal and Central Venous Pressure for Estimating Transpulmonary Pressure ChangesCompletedNCT04443491
- Effectiveness of Convalescent Immune Plasma TherapyCompletedNCT04442958Not applicable
- Chest Physiotherapy in Tracheotomized PatientsCompletedNCT04435535Not applicable
- Physical Rehabilitation in ICU in ARDS Patients With COVID-19CompletedNCT04435080
- ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac SurgeryTerminatedNCT04434001Phase 2
- Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).TerminatedNCT04433546Phase 2
- This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04417036Phase 2
- Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19Status unknownNCT04416139Phase 2
- Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 DiseaseStatus unknownNCT04412395Phase 2
- Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04411459
- Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory FailureStatus unknownNCT04411368
- Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04408326
- CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04404426Not applicable
- Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04402840Not applicable
- Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium NitriteWithdrawnNCT04401527Phase 2
- Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04400032Phase 1/2
- Nebulized Heparin for the Treatment of COVID-19 Induced Lung InjuryTerminatedNCT04397510Phase 4
- A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)Status unknownNCT04395456Phase 2
- Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical TrialTerminatedNCT04395105Phase 3
- Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDSStatus unknownNCT04391140Not applicable
- Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19TerminatedNCT04390152Phase 1/2
- Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19CompletedNCT04390139Phase 1/2
- Predictors of Severe COVID-19 OutcomesCompletedNCT04388813
- Maneuver for Evaluating the Potential Recruitability of the Pulmonary Parenchyme in Patients With ARDSStatus unknownNCT04387669
- Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.CompletedNCT04386720
- Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICUStatus unknownNCT04385004
- Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04384731Phase 2
- Zofin (Organicell Flow) for Patients With COVID-19CompletedNCT04384445Phase 1/2
- Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)CompletedNCT04383730
- Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeCompletedNCT04383678
- Rehabilitation for People With COVID-19 in ICUCompletedNCT04381338Not applicable
- Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04380935Phase 2/3
- A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other CausesCompletedNCT04378920Phase 1/2
- Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICUCompletedNCT04378582
- CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19WithdrawnNCT04378244Phase 1/2
- Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)CompletedNCT04376905
- Human Ab Response & immunoMONItoring of COVID-19 PatientsCompletedNCT04373200Not applicable
- MSCs in COVID-19 ARDSTerminatedNCT04371393Phase 3
- Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19CompletedNCT04370249
- Prono Position and Mechanical PowerCompletedNCT04369105
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 InfectionNo longer availableNCT04366830
- Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeStatus unknownNCT04366063Phase 2/3
- Pilot Study on Cytokine Filtration in COVID-19 ARDSStatus unknownNCT04361526Not applicable
- Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19TerminatedNCT04360096Phase 2/3
- Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 InfectionTerminatedNCT04359862Phase 4
- Different PEEP Settings of COVID-19 Induced ARDSCompletedNCT04359251Not applicable
- Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 PatientsStatus unknownNCT04358627
- Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19CompletedNCT04357444Phase 2
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)TerminatedNCT04355364Phase 3
- Effect of PEEP Titration on the EELV Measured by the Nitrogen Dilution Technique in ARDSStatus unknownNCT04352725Not applicable
- Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress SyndromeCompletedNCT04351906Not applicable
- First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19CompletedNCT04350736Phase 1
- Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDSStatus unknownNCT04350710
- Polyvalent Immunoglobulin in COVID-19 Related ARdsCompletedNCT04350580Phase 3
- Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19TerminatedNCT04347980Phase 3
- Spironolactone in Covid-19 Induced ARDSCompletedNCT04345887
- Hemodynamic Characteristics of Patients With SARS-CoV-2CompletedNCT04337983
- Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)Status unknownNCT04337190
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4
- Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDSCompletedNCT04333368Phase 1/2
- Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDSStatus unknownNCT04331613Phase 1/2
- COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil IIITerminatedNCT04327401Phase 3
- The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated PneumoniaCompletedNCT04325685Not applicable
- Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19TerminatedNCT04325061Phase 4
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
- Complications Related to Transpulmonary ThermodilutionStatus unknownNCT04319965
- Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]Status unknownNCT04317469
- Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm InfantsCompletedNCT04289324Not applicable
- Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress SyndromeCompletedNCT04289194Phase 1/2
- Prone Position and Renal Resistive IndexCompletedNCT04286490Not applicable
- The Effect of Caloric Supplement in the Clinical Outcomes in Acute Lung Injury PatientsStatus unknownNCT04262440
- Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDSCompletedNCT04247477Not applicable
- PEEP and Spontaneous Breathing During ARDSCompletedNCT04241874Not applicable
- Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With ARDS (PReSPON)Status unknownNCT04228471Not applicable
- Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome PatientsCompletedNCT04219150Not applicable
- Breathing Pattern, WOB and Gas Exchange in Patients With Acute Respiratory Distress Syndrome During the Spontaneous Breathing TrialStatus unknownNCT04209270
- The Role of Morphological Phenotype in ARDSCompletedNCT04157946
- Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress SyndromeCompletedNCT04156438Not applicable
- Acute Kidney Injury in Patients With Acute Respiratory Distress SyndromeCompletedNCT04154007
- Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung InjuryCompletedNCT04153487Phase 2
- Early Use of Prone Position in ECMO for Severe ARDSCompletedNCT04139733
- Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after StudyStatus unknownNCT04133740Phase 4
- Pulmonary Microbiota and ARDS MortalityStatus unknownNCT04133558
- Decision Support System to Evaluate VENTilation in ARDSCompletedNCT04115709Not applicable
- Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory DetresseCompletedNCT04106128Not applicable
- Tetracycline to Limit the Innate Immune Response in Acute Respiratory Distress SyndromeStatus unknownNCT04079426
- Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) PathwayCompletedNCT04070053Not applicable